Skip to main content

Table 2 Relationship between factors and lymphedema in ovarian and uterine cancer patients who underwent pelvic lymph node dissection (univariate analysis; N = 680)

From: Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma

Factor

Category

N

No. cases of lymphedema

Lymphedema incidence (%)

p value*

Cancer type

Ovarian

133

28

21.1

 
 

Cervical

252

75

29.8

 
 

Endometrial

295

82

27.8

0.175

Age

< 53 years

342

93

27.2

 
 

≥ 53 years

338

92

27.2

1.000

Retroperitoneal approach**

Closing

457

131

28.7

 
 

Opening

79

24

30.4

0.789

Omentectomy

-

569

160

28.1

 
 

+

111

25

22.5

0.245

Enterectomy

-

670

181

27.0

 
 

+

10

4

40.0

0.473

Salpingo-oophorectomy

-

160

45

28.3

 
 

Unilateral

87

25

28.7

 
 

Bilateral

433

115

26.6

0.873

Hysterectomy

-

12

4

33.3

 
 

Total

206

53

25.7

 
 

Modified radical

196

51

26.0

 
 

Radical

266

77

29.0

0.767

Neo-adjuvant chemotherapy

-

645

173

26.8

 
 

+

35

12

34.3

0.334

Adjuvant chemotherapy

-

393

111

28.2

 
 

+

287

74

25.8

0.487

Post-operative radiation

-

548

136

24.8

 
 

+

132

49

37.1

0.006

Para-aortic lymph node dissection

-

516

133

25.8

 
 

+

164

52

31.7

0.158

Total

 

680

185

27.2

 
  1. * Fisher's exact test
  2. ** Except for 144 patients for whom this information was unknown.